Business Context and Reporting Period
Company: Research Solutions, Inc. (RSSS)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended March 31, 2026
Business Overview: A vertical SaaS and AI company providing software platforms (Discovery, Access, Manage) and transactional services for scientific, technical, and medical (STM) content. The company operates as a single segment and is a smaller reporting company.
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 2026 | Nine Months Ended Mar 31, 2026 |
|---|---|---|
| Total Revenue | $12,121,561 | $36,226,397 |
| Gross Profit | $6,265,532 | $18,667,780 |
| Gross Margin | 51.7% | 51.5% |
| Net Income | $860,206 | $2,156,512 |
| EPS (Diluted) | $0.03 | $0.07 |
| Cash and Equivalents | $12,050,396 | $12,050,396 (Balance Sheet) |
| Operating Cash Flow (9mo) | N/A | $3,499,149 |
| Contingent Earnout Liability | $9,036,809 | $9,036,809 (Balance Sheet) |
Material Changes vs. Prior Period
- Revenue: Total revenue decreased 4.3% ($539,802) for the quarter and 1.1% ($393,667) for the nine months compared to the prior year.
- Platforms: Increased 6.6% (quarter) and 12.6% (nine months) due to new deployments and cross-selling Scite products.
- Transactions: Decreased 11.0% (quarter) and 9.3% (nine months) primarily due to lower paid order volume.
- Profitability: Net income increased 297.4% for the quarter and 297.0% for the nine months. This significant improvement is largely attributable to the absence of a $2.8 million fair value adjustment to the contingent earnout liability recorded in the prior year, alongside improved gross margins and reduced operating expenses.
- Operating Expenses: Total operating expenses decreased 8.6% for the quarter and 3.8% for the nine months. Stock-based compensation expense dropped significantly (58.2% for the quarter) compared to the prior year.
- Liquidity: Cash and cash equivalents decreased slightly by $176,916 over the nine-month period, primarily due to financing activities related to earnout payments.
Outlook, Risks, and Unusual Items
- Contingent Earnout Liability: The company has a significant contingent earnout liability of approximately $9.0 million related to the Scite acquisition. This liability is being paid via a mix of cash and stock over quarterly installments through May 2027. Accreted interest expense of $843,129 was recorded for the nine months ended March 31, 2026.
- Subsequent Events: On May 1, 2026, the company completed the fourth installment of the Scite earnout payment, consisting of $1.2 million in cash and 293,259 shares of common stock.
- Stock Repurchases: The company continues to repurchase shares from employees to satisfy tax withholding obligations. As of March 31, 2026, $114,931 remained under the current authorization.
- Risks: The filing notes no material changes to risk factors from the previous 10-K. Key risks include concentration of credit risk (no single customer >10%), foreign currency fluctuations (costs in Mexican Pesos), and the impact of inflation on operating costs.
- Non-GAAP Measure: Adjusted EBITDA for the nine months ended March 31, 2026, was $4,396,819, an increase of 20.3% from the prior year.
Investor Verification Checklist
- Earnout Obligations: Verify the remaining cash and stock requirements for the Scite earnout payments scheduled through May 2027.
- Transaction Volume Trends: Investigate the drivers behind the consistent decline in transaction revenue (down 9-11% YoY) despite platform growth.
- Stock-Based Compensation: Review the sustainability of the significant reduction in stock-based compensation expense compared to the prior year.
- Deferred Revenue: Analyze the $11.1 million current deferred revenue balance to assess future revenue visibility.
- Vendor Concentration: Note that Vendor A accounts for 27-28% of content costs; verify the stability of this key supplier relationship.